Elixir Medical recently announced that the PINNACLE I study, evaluating the safety and performance of its LithiX Hertz Contact Intravascular Lithotripsy System (IVL) met its primary safety and effectiveness endpoint of clinical success. Shown here: Elixir Medical CEO Motasim Sirhan.
News | EuroPCR
Elixir Medical PINNACLE I Study of LithiX IVL System Meets Primary Endpoints of Clinical Success

May 30, 2024 — Elixir Medical, a developer of technologies to treat cardiovascular and peripheral disease, announced ...

Home May 30, 2024
Home
Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.
News | EP Lab
Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment

May 30, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced ...

Home May 30, 2024
Home
This AI-powered device enables even non-expert ultrasound users
News | Cardiovascular Ultrasound
AI-Powered Ultrasound Device Enhances Cardiac Monitoring for Chemotherapy Patients

May 30, 2024 — A recent study published in the European Heart Journal highlights the significant enhancements that the ...

Home May 30, 2024
Home
New data presented at LINC 2024 support use of thin-strut cobalt chromium stent in calcified iliac lesions
News | Stents Bioresorbable
One-Year BIONETIC-I Study Results Show Safety and Effectiveness of Iliac Artery Treatment With BIOTRONIK’s Dynetic-35 Cobalt Chromium Balloon-Expandable Stent System

May 30, 2024 — Biotronik announced the presentation of the 12-month results from the BIONETIC-I study this week at LINC ...

Home May 30, 2024
Home
Data was presented today byAstraZeneca, at the European Atherosclerosis Society (EAS) Congress in France,on AZD0780, an oral PCSK9 inhibitor which demonstrated significant LDL-C reduction on top of statin in Phase I trial.
News | Cardiovascular Clinical Studies
Oral PCSK9 Inhibitor Demonstrated Significant LDL-C Reduction on Top of Statin in Phase I Trial Presented at EAS Congress

May 29, 2024 — Data was presented by AstraZeneca on AZD0780, an oral PCSK9 inhibitor which demonstrated significant LDL ...

Home May 29, 2024
Home
ROC curves of classification of healthy control (HC) and CHDs.
News | Transesophageal Echo (TEE)
An Auxiliary CHD Diagnostic System Based on Multi-view and Multi-modal Transthoracic Echocardiograms

May 29, 2024 — Congenital heart disease (CHD) is one of the most common congenital anomalies worldwide, which brings a ...

Home May 29, 2024
Home
Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with heart failure, according to research presented at Heart Failure 2024
News | Heart Failure
Heart Failure Patients Who Do Yoga Have Stronger Hearts and Can be More Active

May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with ...

Home May 28, 2024
Home
The American Heart Association has issued a statement warning that false information about COVID vaccination and heart defects attributed to the Association may be spreading.
News | AHA
American Heart Association Warns of Misinformation Connecting COVID Vaccination to Heart Defects

May 24, 2024 — The American Heart Association has issued a statement warning that false information about COVID ...

Home May 24, 2024
Home
Analysis adds to the body of evidence differentiating INPEFA as a dual oral inhibitor of SGLT2 and SGLT1
News | Pharmaceuticals
New Post-Hoc Analysis of Pooled Phase 3 Data Shows That Inpefa (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection Fraction

May 24, 2024 — Lexicon Pharmaceuticals, Inc. announced a new post-hoc analysis of clinical data showing that INPEFA ...

Home May 24, 2024
Home
An AI program developed by Cedars-Sinai investigators might help clinicians detect early, subtle changes in the hearts of patients with undiagnosed arrhythmias
News | Artificial Intelligence
AI May Help Physicians Detect Abnormal Heart Rhythms Earlier

May 24, 2024 — An artificial intelligence (AI) program developed by investigators in the Smidt Heart Institute and their ...

Home May 24, 2024
Home
A new peer-reviewed study published in the Journal of the American Heart Association, JAHA, found that Hello Heart’s digital heart health program was associated with reductions in blood pressure (BP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and weight.
News | Cardiovascular Clinical Studies
Study in JAHA Links Hello Heart Usage to Significant Reductions in Blood Pressure, Cholesterol, and Weight

May 23, 2024 — A newly-published peer-reviewed study in the Journal of the American Heart Association, JAHA, found that ...

Home May 23, 2024
Home
The REVEALPLAQUE trial was a large, global prospective study which enrolled 258 patients across 15 sites in the U.S. and Japan
News | FFR Technologies
HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study

May 23, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) heart care solutions, announced ...

Home May 23, 2024
Home
Real-life data highlights need for patient-centered management of unhealthy cholesterol 
News | Cardiovascular Clinical Studies
Real-life Data Highlights Need for Patient-centered Management of Unhealthy Cholesterol

May 23, 2024 — Global Heart Hub, the international alliance of heart patient organizations, announced the first findings ...

Home May 23, 2024
Home
New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical Center, The University of Texas at Tyler and University of Alabama at Birmingham, shows that exercising, even at very high levels, is not related to the progression of coronary artery calcium (CAC)
News | Heart Failure
Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium

May 22, 2024 — New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical ...

Home May 22, 2024
Home
Voiant (USA) and Thirona (The Netherlands) are pleased to announce they have entered a global commercial partnership, combining Voiant's expertise in supporting clinical trials in pulmonary drug and treatment development with Thirona's expertise in advanced lung image analysis
News | Cardiovascular Business
Voiant and Thirona Announce Commercial Partnership for Full Scope Services in Imaging-based Clinical Trials for Pulmonary Diseases

May 22, 2024 — Voiant (USA) and Thirona (The Netherlands) announced they have entered a global commercial partnership ...

Home May 22, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now